Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Operating Leases (2025 - 2026)

Updated

Curanex Pharmaceuticals' Operating Leases came in at $181,948 for Q2 2026, compared with $5,816 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Operating Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals' Operating Leases was $224,010.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181,948.00
Dec 31, 2025 224,010.00
Jun 30, 2025 5,816.00
API Access

Curanex Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CURX&period=max&api_key=YOUR_API_KEY